{
    "title": "108_s1902",
    "content": "SECTION 1. NATIONAL COMMISSION ON DIGESTIVE DISEASES.\n\n    (a) In General.--The Secretary of Health and Human and Human \nServices (in this section referred to as the ``Secretary''), after \nconsultation with the Director of the National Institutes of Health, \nshall, within 60 days after the date of the enactment of this Act, \nestablish a National Commission on Digestive Diseases (in this section \nreferred to as the ``Commission'').\n    (b) Duties.--\n            (1) In general.--The Commission shall--\n                    (A) conduct a comprehensive study of the present \n                state of knowledge of the incidence, duration, and \n                morbidity of, and mortality rates resulting from, \n                digestive diseases and of the social and economic \n                impact of such diseases;\n                    (B) evaluate the public and private facilities and \n                resources (including trained personnel and research \n                activities) for the diagnosis, prevention, and \n                treatment of, and research in, such diseases; and\n                    (C) identify programs (including biological, \n                behavioral, nutritional, environmental, and social \n                programs) in which, and the means by which, improvement \n                in the management of digestive diseases can be \n                accomplished.\n            (2) Long-range plan.--Based on the study, evaluation, and \n        identification made pursuant to paragraph (1), the Commission \n        shall develop and recommend a long-range plan for the use and \n        organization of national resources to effectively deal with \n        digestive diseases. The plan shall provide for--\n                    (A) research studies into the basic biological \n                processes and mechanisms related to digestive diseases;\n                    (B) investigations into the epidemiology, etiology, \n                diagnosis, treatment, prevention, and control of \n                digestive diseases;\n                    (C) development of preventive measures (including \n                education programs, programs for the elimination of \n                environmental hazards related to digestive diseases, \n                and clinical programs) to be taken against digestive \n                diseases;\n                    (D) detection of digestive diseases in the \n                presymptomatic stages and development and evaluation of \n                new, and improved methods of screening for digestive \n                diseases, taking into account recent technological \n                changes in diagnostic imaging modalities;\n                    (E) development of criteria for the diagnosis and \n                the clinical management and control of digestive \n                diseases;\n                    (F) development of approaches to advance digestive \n                diseases research by incorporating insights obtained \n                from genomic and proteomic research.\n                    (G) development of coordinated health care systems \n                for dealing with digestive diseases;\n                    (H) education and training (including continuing \n                education programs) of scientists, clinicians, \n                educators, and allied health professionals in the \n                fields and specialties requisite to the conduct of \n                programs related to digestive diseases with special \n                emphasis on training for careers in research, teaching, \n                and all aspects of patient care;\n                    (I) the conduct and subject matter of trials in \n                clinical and translational research in digestive \n                diseases; and\n                    (J) establishment of a system of periodic \n                surveillance of the research potential and research \n                needs in digestive diseases;\nThe long-range plan formulated under this paragraph shall also include \nwithin its scope related nutritional disorders and basic biological \nprocesses and mechanisms in nutrition which are related to digestive \ndiseases.\n            (3) Recommendations for individual national research \n        institutes.--The Commission shall recommend for each of the \n        Institutes of the National Institutes of Health whose \n        activities are to be affected by the long-range plan estimates \n        of the expenditures needed to carry out each Institute's part \n        of the overall program. Such estimates shall be prepared for \n        the fiscal year beginning immediately after completion of the \n        Commission's plan and for each of the next 5 fiscal years.\n    (c) Composition.--\n            (1) In general.--The Commission shall be composed of 16 \n        members appointed in accordance with paragraph (2) and the ex \n        officio members designated under paragraph (3). The appointed \n        members shall be voting members, and the ex officio members \n        shall be nonvoting members, except that the ex officio member \n        designated under paragraph (3)(A) shall be a voting member.\n            (2) Appointed members.--The voting members of the \n        Commission shall be appointed by the Secretary from among \n        individuals who are not officers or employees of the Federal \n        Government. Of such members--\n                    (A) 10 shall be appointed from among scientists, \n                physicians, and other health professionals, of whom--\n                            (i) two shall be practicing clinical \n                        gastroenterologists;\n                            (ii) two shall be gastroenterologists \n                        involved primarily in research on digestive \n                        diseases;\n                            (iii) one shall be a surgeon;\n                            (iv) one shall be an expert in liver \n                        disease;\n                            (v) one shall be an epidemiologist;\n                            (vi) one shall be an allied health \n                        professional; and\n                            (vii) two shall be basic biomedical \n                        scientists (such as biochemists, physiologists, \n                        microbiologists, nutritionists, \n                        pharmacologists, or immunologists); and\n                    (B) six shall be appointed from among the general \n                public, of whom at least three shall have personal or \n                close family experience with digestive diseases.\n            (3) Ex officio members.--\n                    (A) National institute of diabetes and digestive \n                and kidney diseases.--From among officers or employees \n                of the National Institute of Diabetes and Digestive and \n                Kidney Diseases whose primary interest is in the field \n                of digestive diseases, the Secretary shall designate an \n                individual to serve as an ex officio member of the \n                Commission.\n                    (B) Additional members.--The following officials \n                (or the designees of the officials) shall serve as ex \n                officio members of the Commission: The Director of the \n                National Institutes of Health; the Director of the \n                National Institute of Diabetes and Digestive and Kidney \n                Diseases; the Director of the National Institute of \n                Allergy and Infectious Diseases; the Director of the \n                National Cancer Institute; the Director of the National \n                Institute of Biomedical Imaging and Bioengineering; the \n                Director of the National Institute of Drug Abuse; the \n                Director of the National Institute on Alcohol Abuse and \n                Alcoholism; the Director of the National Human Genome \n                Research Institute; the Director for the Division of \n                Digestive Diseases and Nutrition within the National \n                Institute of Diabetes and Digestive Kidney Diseases; \n                the Director of the Centers for Disease Control and \n                Prevention; the Chief Medical Director of the \n                Department of Veterans Affairs; and the Secretary of \n                Defense.\n    (d) Chair.--From among the appointed members of the Commission, the \nmembers of the Commission shall select an individual to serve as the \nChair of the Commission.\n    (e) Terms.--The term of a member of the Commission is the life of \nthe Commission.\n    (f) Vacancies.--\n            (1) Authority of commission.--A vacancy in the membership \n        of the Commission does not affect the power of the remaining \n        members to carry out the duties of the Commission.\n            (2) Appointment of successor.--A vacancy in the membership \n        of the Commission shall be filled in the manner in which the \n        original appointment was made.\n            (3) Incomplete term.--If a member of the Commission does \n        not serve the full term of the member, the individual appointed \n        to fill the resulting vacancy shall be appointed for the \n        remainder of the term of the predecessor of the individual.\n    (g) Meetings.--The Commission shall first meet as directed by the \nSecretary, not later than 60 days after the Commission is established, \nand thereafter shall meet at the call of the Chair of the Commission, \nbut not less often than three times during the life of the Commission.\n    (h) Compensation; Reimbursement of Expenses.--\n            (1) Appointed members.--Members of the Commission appointed \n        from among individuals who are not officers or employees of the \n        Federal Government shall receive compensation for each day \n        (including travel time) engaged in carrying out the duties of \n        the Commission. Such compensation may not be in an amount in \n        excess of the daily equivalent of the annual maximum rate of \n        basic pay payable under section 5108 of title 5, United States \n        Code, for positions above GS-15.\n            (2) Ex officio members.--Members of the Commission \n        appointed from among individuals who are officers or employees \n        of the Federal Government may not receive compensation for \n        service on the Commission in addition to the compensation \n        otherwise received for duties carried out as Federal officers \n        or employees.\n            (3) Reimbursement.--Members of the Commission, while \n        serving away from their homes or regular places of business in \n        the performance of services for the Commission, shall be \n        allowed travel expenses, including per diem in lieu of \n        subsistence, in the same manner as such expenses are authorized \n        by section 5703 of title 5, United States Code, for persons in \n        Government service employed intermittently.\n    (i) Staff.--\n            (1) Executive director.--The Commission may appoint and fix \n        the pay of an executive director to effectively carry out its \n        functions. The executive director shall be appointed subject to \n        the provisions of title 5, United States Code, governing \n        appointments in the competitive service, and shall be paid in \n        accordance with the provisions of chapter 51 and subchapter III \n        of chapter 53 of such title related to classification and \n        General Schedule pay rates.\n            (2) Additional staff.--The Secretary shall provide the \n        Commission with such additional professional and clerical \n        staff, such information, and the services of such consultants \n        as the Secretary determines to be necessary for the Commission \n        to carry out effectively its functions.\n    (j) Powers.--The Commission may hold such hearings, take such \ntestimony, and sit and act at such time and places as the Commission \ndeems advisable.\n    (k) Report.--Within 18 months following its initial meetings (as \nprescribed by subsection (g)), the Commission shall publish and \ntransmit directly to Congress a final report respecting its activities \nunder this section. The report shall contain--\n            (1) the long-range plan required by subsection (b)(2);\n            (2) the expenditure estimates required by subsection \n        (b)(3); and\n            (3) any recommendations of the Commission for legislation \n        that would facilitate the implementation of the long-range \n        plan.\nIn developing recommendations under paragraph (3), the Commission shall \nevaluate the effectiveness of the Interagency Coordinating Committee \nfor Digestive Diseases and assess its ability to monitor and promote \nadherence to the long-range plan. The Commission may also make \nrecommendations regarding organizational changes within the National \nInstitutes of Health or the establishment of new entities that would \nfacilitate implementation of the long-range plan and otherwise \ncoordinate the Federal digestive diseases research effort.\n    (l) Termination.--The Commission terminates 30 days after the date \non which the final report under subsection (k) is submitted to \nCongress.\n    (m) Authorization of Appropriations.--For the purpose of carrying \nout this section, there is authorized to be appropriated $4,000,000 in \nthe aggregate for fiscal years 2005 and 2006."
}